Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q4 FY262026-06-30 | Q3 FY262026-03-31 | Q2 FY262025-12-31 | Q1 FY262025-09-30 | Q4 FY252025-06-30 | Q3 FY252025-03-31 | Q2 FY252024-12-31 | Q1 FY252024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.95B | $1.67B | $1.67B | $1.43B | $1.99B | $1.67B | $1.69B | $1.76B |
| Cost of revenue | $1.14B | $948.00M | $951.00M | $833.00M | $1.06B | $924.00M | $948.00M | $955.00M |
| Gross profit | $804.00M | $722.00M | $722.00M | $596.00M | $924.00M | $744.00M | $738.00M | $807.00M |
| Gross margin | 41.3% | 43.2% | 43.2% | 41.7% | 46.5% | 44.6% | 43.8% | 45.8% |
| Research and development | $32.00M | $27.00M | $29.00M | $28.00M | $32.00M | $27.00M | $31.00M | $31.00M |
| Selling, general and administrative | $514.00M | $406.00M | $452.00M | $443.00M | $467.00M | $474.00M | $471.00M | $482.00M |
| Operating expenses | $546.00M | $433.00M | $481.00M | $471.00M | $499.00M | $501.00M | $502.00M | $513.00M |
| Operating income | $258.00M | $289.00M | $241.00M | $125.00M | $425.00M | $243.00M | $236.00M | $294.00M |
| Operating margin | 13.2% | 17.3% | 14.4% | 8.7% | 21.4% | 14.6% | 14.0% | 16.7% |
| EBITDA | $336.00M | $347.00M | $296.00M | $181.00M | $482.00M | $298.00M | $289.00M | $348.00M |
| Interest expense | −$55.00M | −$27.00M | −$25.00M | −$23.00M | −$22.00M | −$23.00M | −$22.00M | −$21.00M |
| Income before taxes | $213.00M | $256.00M | $215.00M | $107.00M | $410.00M | $254.00M | $237.00M | $177.00M |
| Income taxes | $46.00M | $65.00M | $54.00M | $25.00M | $74.00M | $63.00M | $43.00M | $74.00M |
| Net income | $167.00M | $191.00M | $161.00M | $82.00M | $336.00M | $191.00M | $194.00M | $103.00M |
| Net margin | 8.6% | 11.4% | 9.6% | 5.7% | 16.9% | 11.5% | 11.5% | 5.8% |
| EPS, basic | $1.34 | $1.54 | $1.29 | $0.65 | $2.70 | $1.51 | $1.55 | $0.80 |
| EPS, diluted | $1.34 | $1.54 | $1.29 | $0.65 | $2.68 | $1.50 | $1.54 | $0.80 |
| Diluted shares | 121.81M | 121.79M | 121.92M | 123.02M | 123.74M | 124.07M | 124.66M | 124.68M |
Figures describe Clorox shares, not any token. As of Aug 7, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.